• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Antibody-Bactericidal Macrocyclic Peptide Conjugates to Target Gram Negative Bacteria

September 14, 2018 | Chembiochem: A European Journal of Chemical Biology
Fayçal Touti et al.

Antibody-Bactericidal Macrocyclic Peptide Conjugates to Target Gram Negative Bacteria

Fayçal Touti, Guillaume Lautrette, Kenneth D Johnson, James C Delaney, Andrew Wollacott, Hamid Tissire, Karthik Viswanathan, Zachary Shriver, Surin K Mong, Alexander J Mijalis, Obadiah J Plante, Bradley L Pentelute

>READ

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design